GTBP

Conviction 19HealthcareScan · Thu, Jun 25, 2026

GTBP$0.4161-8.77%

ResistanceSupportVol 14

Vol MA14 1.48M

Mar 26Apr 14May 1May 19Jun 8Jun 25

GT Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.gtbiopharma.com ↗

Price0.4161

Change-8.77%

Gap-1.34%

Rel volume1.06×

Avg volume1.68M

Avg $ vol772.85K

SMA 200.4535

SMA 500.4025

SMA 2000.5738

Price vs 50+3.37%

Price vs 200-27.48%

MA stackmixed

50/200 cross—

Supertrendup · 0.3743

RSI (14)46

MACD hist-0.00

MACD crossbear · 0d

Stoch %K / %D15 / 39

ADX (14)26

+DI / −DI23 / 19

RSI divergence—

MACD divergenceBearish

ATR %+11.65%

ADR %10.49%

52w high3.80

52w low0.2720

From 52w high-89.05%

Above 52w low+52.98%

New 52w highNo

SqueezeOn · 10d

Bollinger width23.61%

%B0.15

Donchian pos24.60%

Donchian high0.5574

Donchian low0.3700

AVWAP (52w high)0.7094

vs AVWAP high-41.35%

AVWAP (52w low)0.4311

vs AVWAP low-3.48%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d1.06×

Avg vol (14d)1.48M

Avg vol (20d)1.68M

Avg $ vol (20d)772.85K

Market cap15.01M

RS 3m (vs SPY)-16.26%

RS 6m (vs SPY)-47.48%

RS line new highNo

Trend template2/8

Technical rank30.3

1 week-9.35%

1 month+6.15%

3 months-10.52%

6 months-46.23%

1 year-87.47%

YTD-49.08%

P/E-0.53

P/B1.98

P/S—

P/FCF-1.16

EPS-6.68

Div yield1.53%

ROE-374.06%

ROA-349.79%

Debt/Eq—

Current4.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-115.42%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value6.08M

Revenue0

Net income-2.83M

Gross profit0

Free cash flow-12.91M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.06M

Employees1

ListedThu, Feb 11, 2021

Free float29.5M

Float %93.5%

Short interest2M

Days to cover1.0d

Short volume55.4%

Squeeze score30 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank30.3 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.5262

Support0.3354

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GTBP

All disclosures →

No recent disclosed trades by Congress in GTBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GTBP

No recent insider (Form 4) filings in GTBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GTBP · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.